[Medical treatment of L-dopa induced dyskinesia].
Kuno
S
S
Department of Neurology and Clinical Research Center, Utano National Hospital.
D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects*; D018491:Dopamine Agonists / Q000008:administration & dosage; D018492:Dopamine Antagonists / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects*; D008996:Monoamine Oxidase Inhibitors / Q000008:administration & dosage; D010300:Parkinson Disease / Q000188:drug therapy*
D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D018492:Dopamine Antagonists; D008996:Monoamine Oxidase Inhibitors; D007980:Levodopa